Redefining Speed and Flexibility in Infectious Disease Trials
Tailored solutions to meet your research needs
Helping Accelerate Your Infectious Disease Trials
Finding effective treatments and vaccines for viral, bacterial, and fungal infections is critical to helping advance global health. But infectious disease research is a dynamic space that requires a partner with a nimble approach; one that requires having the right resources at the right time to meet timelines.
Meeting the needs of sponsors and CROs during the COVID-19 pandemic means that the experts at WCG are ready for your next infectious disease and vaccine trials. WCG’s novel solutions can help your organization meet the need for both speed and flexibility.
A suite of solutions to accelerate your infectious disease and vaccine trials:
Protocol Planning
Total Feasibility
IRB Review
Study Administration Support
Infectious Disease and Vaccine Case Studies
WCG Randomized 1,600+ Participants for RSV Vaccine Trial
Case Studies
Sponsor’s Groundbreaking Pneumococcal Vaccine Portfolio Receives FDA Priority Review with Support from WCG
Case Studies
WCG IRB’s Response to COVID-19 in 2020: Supporting the Clinical Trial Industry When It Needed It the Most
Case StudiesAct quickly, expedite start-up, and manage risks with WCG. Schedule a consultation today.
Interested to see how WCG can improve your infectious disease study?
Complete the form to schedule a consultation with WCG. We’ll share benchmark data from the WCG Knowledge Base, analyze your results, and share some of the common practices of top performers.